Annexon ANNX
NASDAQ ANNX
$4.12 -0.11 (-2.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Annexon (ANNX) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Annexon (ANNX) posted Liabilities and Shareholders Equity of $246.07 million for Q2 2026, down 7.0% from $264.57 million a year earlier and down 6.4% from the prior quarter.

Analysis

Annexon (ANNX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Annexon's Liabilities and Shareholders Equity came in at $277.57 million, down 20.7% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
  • In prior years, Annexon's Liabilities and Shareholders Equity was $350.07 million in FY2024 (+17.6%), $297.67 million in FY2023 (+4.4%), $285.1 million in FY2022 (-0.7%) and $287.04 million in FY2021 (-19.4%).
  • Quarterly Liabilities and Shareholders Equity has run from a low of $203.82 million in Q3 2023 to a high of $406.09 million in Q2 2024 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last six quarters, with an average decline of 1.5% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2024, with growth of 85.8%; the weakest was Q3 2025, with a decline of 39.5%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $262.89 million (Q1 2026), $277.57 million (Q4 2025) and $229.14 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Annexon 738.58 Mn 738.58 Mn - 246.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 246.07 Mn
Mar 31, 2026 262.89 Mn
Dec 31, 2025 277.57 Mn
Sep 30, 2025 229.14 Mn
Jun 30, 2025 264.57 Mn
Mar 31, 2025 303.03 Mn
Dec 31, 2024 350.07 Mn
Sep 30, 2024 378.78 Mn
Jun 30, 2024 406.09 Mn
Mar 31, 2024 304.07 Mn
Dec 31, 2023 297.67 Mn
Sep 30, 2023 203.82 Mn
Jun 30, 2023 233.01 Mn
Mar 31, 2023 268.78 Mn
Dec 31, 2022 285.10 Mn
Sep 30, 2022 312.72 Mn
Jun 30, 2022 220.70 Mn
Mar 31, 2022 250.57 Mn
Dec 31, 2021 287.04 Mn
Sep 30, 2021 310.16 Mn
API Access

Annexon Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANNX&period=max&api_key=YOUR_API_KEY